Anlon Healthcare Limited (NSE:AHCL)

India · Delayed Price · Currency is INR

26.73

-0.21 (-0.78%)

At close: Nov 12, 2026

Market Cap	14.21B +87.6%
Revenue (ttm)	2.80B +94.5%
Net Income	356.77M +32.0%
EPS	0.86 +29.2%
Shares Out	531.52M
PE Ratio	31.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,170,009
Open	27.36
Previous Close	26.94
Day's Range	26.58 - 27.73
52-Week Range	10.37 - 37.24
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About Anlon Healthcare

Anlon Healthcare Limited manufactures and sells active pharmaceutical ingredients in India and internationally. The company also offers bulk drugs; advanced pharmaceutical intermediates; nutraceutical API products; and drug intermediates. It also manufactures loxoprofen sodium dihydrate, ketoprofen, and dexketoprofen trometamol products for pain management and anti-inflammatory therapies. Anlon Healthcare Limited was incorporated in 2013 and is based in Rajkot, India. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2013

Employees 119

Stock Exchange National Stock Exchange of India

Ticker Symbol AHCL

Full Company Profile

Financial Performance

In fiscal year 2026, Anlon Healthcare's revenue was 1.72 billion, an increase of 42.95% compared to the previous year's 1.20 billion. Earnings were 285.14 million, an increase of 38.97%.

Financial Statements